| Literature DB >> 33490092 |
Xinyu Wu1, Jialing Wu1, Xiaomin Li1, Qiujing Wei1, Qing Lv1, Pingping Zhang2, Xuqi Zheng1, Zena Chen1, Shuangyan Cao1, Liudan Tu1, Jieruo Gu1.
Abstract
HLA-B27 has an established relationship with the development of ankylosing spondylitis (AS). After reviewing the HLA-B genotype from 407 Chinese subjects (318 patients and 89 sex-matched controls), we found that 252 patients and 32 controls were HLA-B27(+) and that HLA-B*27:04 was the dominant HLA-B27 subtype (N = 224). In all participants, HLA*27:04 homozygous were only detected in two patients. In the HLA-B27(+) group, HLA-B40 was observed in 51 cases and one control (p < 0.05, OR = 7.87, 95% CI 1.05-59.0); of these, the most genotype was HLA-B*27:04/B*40:01(N = 38). Two hundred thirty-nine patients' clinical information was recorded. Cases with HLA-B27/B46 had more peripheral joint involvement (OR = 3.95, 95% CI 1.77-8.79) in HLA-B27(+) AS. HLA-B*15:02 may be a significant risk element to peripheral joint involvement (p < 0.05) in HLA-B27(-) patients. Therefore, we believe HLA-B*40:01, HLA-B*46:01, and HLA-B*15:02 can be the test indicators for AS diagnostic value.Entities:
Keywords: HLA-B genotype; HLA-B40; HLA-B46; ankylosing spondylitis; peripheral joint involvement
Year: 2021 PMID: 33490092 PMCID: PMC7820707 DOI: 10.3389/fmed.2020.568790
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X